Related references
Note: Only part of the references are listed.Pharmacodynamics of SMP-601 (PTZ601) against Vancomycin-Resistant Enterococcus faecium and Methicillin-Resistant Staphylococcus aureus in Neutropenic Murine Thigh Infection Models
Ken Eguchi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Bacterial Strain-to-Strain Variation in Pharmacodynamic Index Magnitude, a Hitherto Unconsidered Factor in Establishing Antibiotic Clinical Breakpoints
Alasdair P. MacGowan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Resistance Selection Studies Comparing the Activity of Razupenem (PTZ601) to Vancomycin and Linezolid against Eight Methicillin-Resistant and Two Methicillin-Susceptible Staphylococcus aureus Strains
Catherine Clark et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Activity of the anti-MRSA carbapenem razupenem (PTZ601) against Enterobacteriaceae with defined resistance mechanisms
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Pharmacodynamics of the antibacterial effect and emergence of resistance to tomopenem, formerly RO4908463/CS-023, in an in vitro pharmacokinetic model of Staphylococcus aureus infection
Alasdair P. MacGowan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Pharmacodynamics of dalbavancin studied in an in vitro pharmacokinetic system
Karen E. Bowker et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem
Y Ueda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Pharmacodynamic profile of ertapenem against Klebsiella pneumoniae and Escherichia coli in a murine thigh model
D Maglio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Activities of moxifloxacin against, and emergence of resistance in, Streptococcus pneumoniae and Pseudomonas aeruginosa in an in vitro pharmacokinetic model
AP MacGowan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Share Paper
